175 related articles for article (PubMed ID: 37493814)
1. Antitumor activity of 5-fluorouracil polymeric nanogel synthesized by gamma radiation on a rat model of colon carcinoma: a proposed mechanism.
Abo-Zaid OAR; Moawed FSM; Barakat WEM; Ghobashy MM; Ahmed ESA
Discov Oncol; 2023 Jul; 14(1):138. PubMed ID: 37493814
[TBL] [Abstract][Full Text] [Related]
2. Curcumin synergizes with 5-fluorouracil by impairing AMPK/ULK1-dependent autophagy, AKT activity and enhancing apoptosis in colon cancer cells with tumor growth inhibition in xenograft mice.
Zhang P; Lai ZL; Chen HF; Zhang M; Wang A; Jia T; Sun WQ; Zhu XM; Chen XF; Zhao Z; Zhang J
J Exp Clin Cancer Res; 2017 Dec; 36(1):190. PubMed ID: 29273065
[TBL] [Abstract][Full Text] [Related]
3. Melatonin synergizes the chemotherapeutic effect of 5-fluorouracil in colon cancer by suppressing PI3K/AKT and NF-κB/iNOS signaling pathways.
Gao Y; Xiao X; Zhang C; Yu W; Guo W; Zhang Z; Li Z; Feng X; Hao J; Zhang K; Xiao B; Chen M; Huang W; Xiong S; Wu X; Deng W
J Pineal Res; 2017 Mar; 62(2):. PubMed ID: 27865009
[TBL] [Abstract][Full Text] [Related]
4. Design of pH-responsive polymeric nanocarrier for targeted delivery of pyrogallol with enhanced antitumor potential in colon cancer.
Mahmoud GA; Ali HE; Radwan RR
Arch Biochem Biophys; 2022 Nov; 731():109431. PubMed ID: 36243140
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic synergy between dual phosphoinositide-3-kinase and mammalian target of rapamycin inhibition and 5-fluorouracil in PIK3CA mutant gastric cancer cells.
Bhattacharya B; Akram M; Balasubramanian I; Tam KK; Koh KX; Yee MQ; Soong R
Cancer Biol Ther; 2012 Jan; 13(1):34-42. PubMed ID: 22336586
[TBL] [Abstract][Full Text] [Related]
6. Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer.
Li S; Tian J; Zhang H; Zhou S; Wang X; Zhang L; Yang J; Zhang Z; Ji Z
Apoptosis; 2018 Jun; 23(5-6):356-374. PubMed ID: 29777330
[TBL] [Abstract][Full Text] [Related]
7. Piclamilast mitigates 1,2-dimethylhydrazine induced colon cancer in rats through modulation of Ras/PI3K/Akt/mTOR and NF-κβ signaling.
Abdel-Wahab BA; Alqhtani H; Walbi IA; Albarqi HA; Aljadaan AM; Khateeb MM; Hassanein EHM
Chem Biol Interact; 2021 Dec; 350():109686. PubMed ID: 34627785
[TBL] [Abstract][Full Text] [Related]
8. Reposition of the anti-inflammatory drug diacerein in an
Abdel-Latif RT; Wadie W; Abdel-Mottaleb Y; Abdallah DM; El-Maraghy NN; El-Abhar HS
Saudi Pharm J; 2022 Jan; 30(1):72-90. PubMed ID: 35145347
[TBL] [Abstract][Full Text] [Related]
9. In Vivo and In Vitro Enhanced Tumoricidal Effects of Metformin, Active Vitamin D
Almaimani RA; Aslam A; Ahmad J; El-Readi MZ; El-Boshy ME; Abdelghany AH; Idris S; Alhadrami M; Althubiti M; Almasmoum HA; Ghaith MM; Elzubeir ME; Eid SY; Refaat B
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326689
[TBL] [Abstract][Full Text] [Related]
10. Metformin in combination with 5-fluorouracil suppresses tumor growth by inhibiting the Warburg effect in human oral squamous cell carcinoma.
Harada K; Ferdous T; Harada T; Ueyama Y
Int J Oncol; 2016 Jul; 49(1):276-84. PubMed ID: 27210058
[TBL] [Abstract][Full Text] [Related]
11. Effects of hexahydrocurcumin in combination with 5-fluorouracil on dimethylhydrazine-induced colon cancer in rats.
Srimuangwong K; Tocharus C; Tocharus J; Suksamrarn A; Chintana PY
World J Gastroenterol; 2012 Dec; 18(47):6951-9. PubMed ID: 23322993
[TBL] [Abstract][Full Text] [Related]
12. Elucidation of underlying molecular mechanism of 5-Fluorouracil chemoresistance and its restoration using fish oil in experimental colon carcinoma.
Rani I; Kumar S; Sharma B; Prasad R; Kaur S; Sharma P; Agnihotri N
Mol Cell Biochem; 2021 Mar; 476(3):1517-1527. PubMed ID: 33392922
[TBL] [Abstract][Full Text] [Related]
13. Effective inhibition of colon cancer cell growth with MgAl-layered double hydroxide (LDH) loaded 5-FU and PI3K/mTOR dual inhibitor BEZ-235 through apoptotic pathways.
Chen J; Shao R; Li L; Xu ZP; Gu W
Int J Nanomedicine; 2014; 9():3403-11. PubMed ID: 25075187
[TBL] [Abstract][Full Text] [Related]
14. Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin.
Bommer UA; Vine KL; Puri P; Engel M; Belfiore L; Fildes K; Batterham M; Lochhead A; Aghmesheh M
Cell Commun Signal; 2017 Feb; 15(1):9. PubMed ID: 28143584
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of the antitumor effect of 5-fluorouracil with modulation in drug transporters expression using PI3K inhibitors in colorectal cancer cells.
El-Daly SM; Abo-Elfadl MT; Hussein J; Abo-Zeid MAM
Life Sci; 2023 Feb; 315():121320. PubMed ID: 36574946
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA H19 promotes chemotherapy resistance in choriocarcinoma cells.
Yu S; Wu C; Tan Q; Liu H
J Cell Biochem; 2019 Sep; 120(9):15131-15144. PubMed ID: 31020694
[TBL] [Abstract][Full Text] [Related]
17. Curcumae longae Rhizoma (Jianghuang) extract reverses the 5-Fluoruracil resistance in colorectal cancer cells via TLR4/PI3K/Akt/mTOR pathway.
Teng Z; Sun X; Guo Y; Zhang M; Liu Y; Xu M
Clin Res Hepatol Gastroenterol; 2022 Nov; 46(9):101976. PubMed ID: 35710041
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway.
Xu J; Zhang S; Wang R; Wu X; Zeng L; Fu Z
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28432271
[TBL] [Abstract][Full Text] [Related]
19. Noscapine Induces Apoptosis in Human Colon Cancer Cells by Regulating Mitochondrial Damage and Warburg Effect via PTEN/PI3K/mTOR Signaling Pathway.
Tian X; Liu M; Huang X; Zhu Q; Liu W; Chen W; Zou Y; Cai Y; Huang S; Chen A; Zhan T; Huang M; Chen X; Han Z; Tan J
Onco Targets Ther; 2020; 13():5419-5428. PubMed ID: 32606759
[TBL] [Abstract][Full Text] [Related]
20. Berberine Exerts Anti-cancer Activity by Modulating Adenosine Monophosphate- Activated Protein Kinase (AMPK) and the Phosphatidylinositol 3-Kinase/ Protein Kinase B (PI3K/AKT) Signaling Pathways.
Huang J; Feng W; Li S; Tang H; Qin S; Li W; Gong Y; Fang Y; Liu Y; Wang S; Guo Y; Xu Z; Shen Q
Curr Pharm Des; 2021; 27(4):565-574. PubMed ID: 32988344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
